M&A Deal Summary

Calibre Scientific Acquires Anatrace

On October 14, 2013, Calibre Scientific acquired life science company Anatrace from Affymetrix

Acquisition Highlights
  • This is Calibre Scientific’s 1st transaction in the Life Science sector.
  • This is Calibre Scientific’s 1st transaction in the United States.
  • This is Calibre Scientific’s 1st transaction in Ohio.

M&A Deal Summary
Date 2013-10-14
Target Anatrace
Sector Life Science
Buyer(s) Calibre Scientific
Sellers(s) Affymetrix
Deal Type Divestiture

Target

Anatrace

Maumee, Ohio, United States
website
Anatrace is a developer, manufacturer and distributor of unique, high purity detergents and synthetic lipids for use in membrane protein studies. Anatrace is based in Maumee, Ohio.

Search 193,103 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Calibre Scientific

Los Angeles, California, United States

website

Category Company
Sector Life Science
DESCRIPTION

Calibre Scientific represents a portfolio of niche life science companies, across various key verticals, that have an unrivaled ability to address the unique challenges of their respective markets. Calibre Scientific is based in Los Angeles, California.

DEAL STATS #
Overall 1 of 31
Sector (Life Science) 1 of 7
Type (Divestiture) 1 of 2
State (Ohio) 1 of 2
Country (United States) 1 of 7
Year (2013) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-01 Edge Biosystems

Gaithersburg, Maryland, United States

EdgeBio is an established research reagents and sequencing services company.

Buy -

Seller(S) 1

SELLER

Affymetrix

Santa Clara, California, United States

website

Category Company
Founded 1991
Sector Medical Products
Employees1,200
Revenue 349M USD (2014)
DESCRIPTION

Affymetrix develops and provides technologies that enable multiplex and parallel analysis of biological systems at the cell, protein, and gene level, facilitating the rapid translation of results into biology for a better world.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Ohio) 1 of 1
Country (United States) 1 of 1
Year (2013) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-11-30 eBioscience

San Diego, California, United States

eBioscience, Inc. offers flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics.

Buy $330M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-05-14 Eureka Genomics

Houston, Texas, United States

Eureka Genomics Corp. is a developer of cost-effective, low- to mid-plex, high throughput genotyping assays that use common next-generation sequencing (NGS) platforms for signal readout.

Buy $15M
Mergr

Product

Company

Legal